In this issue:
Updates to NCCN Clinical Practice Guidelines
European epidemiology of pleural mesothelioma
Mesothelioma in Australia
Results from NIPU trial of UV1 vaccine in refractory pleural mesothelioma
MARS 2: No benefit to pleurectomy decortication
Outcomes of immunotherapy for pleural mesothelioma in Australia
Could a breath test enable detection of latent mesothelioma?
Pembrolizumab has anti-cancer activity in peritoneal mesothelioma
ESMO Clinical Practice Guidelines for pleural mesothelioma
Is universal germline testing warranted in mesothelioma?
MESOPEC: adjuvant autologous DCBI feasible for peritoneal mesothelioma
Cytoreductive surgery + HIPEC effective for peritoneal mesothelioma
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)